| Literature DB >> 23186309 |
Abstract
A distinction is made between the clinical and public health justifications for screening and brief intervention (SBI) against hazardous and harmful alcohol consumption. Early claims for a public health benefit of SBI derived from research on general medical practitioners' (GPs') advice on smoking cessation, but these claims have not been realized, mainly because GPs have not incorporated SBI into their routine practice. A recent modeling exercise estimated that, if all GPs in England screened every patient at their next consultation, 96% of the general population would be screened over 10 years, with 70-79% of excessive drinkers receiving brief interventions (BI); assuming a 10% success rate, this would probably amount to a population-level effect of SBI. Thus, a public health benefit for SBI presupposes widespread screening; but recent government policy in England favors targeted versus universal screening, and in Scotland screening is based on new registrations and clinical presentation. A recent proposal for a national screening program was rejected by the UK National Health Service's National Screening Committee because 1) there was no good evidence that SBI led to reductions in mortality or morbidity, and 2) a safe, simple, precise, and validated screening test was not available. Even in countries like Sweden and Finland, where expensive national programs to disseminate SBI have been implemented, only a minority of the population has been asked about drinking during health-care visits, and a minority of excessive drinkers has been advised to cut down. Although there has been research on the relationship between treatment for alcohol problems and population-level effects, there has been no such research for SBI, nor have there been experimental investigations of its relationship with population-level measures of alcohol-related harm. These are strongly recommended. In this article, conditions that would allow a population-level effect of SBI to occur are reviewed, including their political acceptability. It is tentatively concluded that widespread dissemination of SBI, without the implementation of alcohol control measures, might have indirect influences on levels of consumption and harm but would be unlikely on its own to result in public health benefits. However, if and when alcohol control measures were introduced, SBI would still have an important role in the battle against alcohol-related harm.Entities:
Mesh:
Year: 2012 PMID: 23186309 PMCID: PMC3507632 DOI: 10.1186/1940-0640-7-15
Source DB: PubMed Journal: Addict Sci Clin Pract ISSN: 1940-0632
Three intervention models from the Sheffield Alcohol Policy Model, version 2
| Practice nurse undertakes both screening and, where appropriate, BI | Physician undertakes both screening and, where indicated, BI as part of consultation | Prescreen applied depending on reason for attendance or diagnosis, screening prior to discharge, BI offered as a separate appointment on day after screening | |
| | ► Screening using full AUDIT followed by 25-minute intervention | ► Screening using full AUDIT followed by 25-minute intervention | ► Assume 30% take-up of BI, prescreen similar to PAT, screening with FAST, followed by 50-minute intervention |
| | ► Screening using AUDIT-C followed by 5-minute intervention (similar to DES configuration) | ► Screening using AUDIT-C followed by 5-minute intervention (similar to DES configuration) | |
| | ► Screening using FAST followed by 5-minute intervention | ► Screening using FAST followed by 5-minute intervention | |
| In all three cases, estimated costs of delivering BI outweighed by financial savings due to subsequent reduced burden of illness | For 25-minute BI, estimated costs outweigh health-care costs avoided, with net cost overall and ICER of £5,900 per QALY gained (i.e., cost-effective) | ICER estimated at £9,700 per QALY (i.e., cost-effective) | |
| | QALY gains and, therefore, baseline interventions estimated to be better than “doing nothing” | For 5-minute BI, intervention costs lower and ICER improved, i.e., cost-savings | Despite 10-year program involving screening over three-fourths of adult population, only 18% of hazardous/harmful drinkers estimated to receive BI due to low take-up rate of 30% |
| | Screening on next registration estimated to apply to 39% of population of England over 10-year period, with one-third of hazardous and harmful drinkers being screened, detected, and given BI | Different from next GP registration because | |
| | | ► GP staff costs higher than those of practice nurse | |
| | | ► Men consult less frequently than women | |
| | | ► Patients consult GP much more frequently than they change GP | |
| | | Thus, 96% of population screened over 10 years (the majority in the first year) with 70-79% hazardous/harmful drinkers receiving BI | |
| Estimated gain is over 100,000 QALYs over 10-year screening program |
GP = general practice; ED = emergency department; BI = brief intervention; AUDIT = Alcohol Use Disorders Identification Test (AUDIT-C = three AUDIT consumption questions); DES = direct enhanced service; PAT = Paddington Alcohol Test; FAST = Fast Alcohol Screening Test; ICER = incremental cost-effectiveness ratio; QALY = quality-adjusted life year.
Criteria used by the UK National Screening Committee for the appraisal of a new formal screening program and verdict applied to alcohol misuse
| 1. The condition should be an important health problem | √ | |
| 2. The epidemiology and natural history of the condition, including development from latent to declared disease, should be adequately understood, and there should be a detectable risk factor, disease marker, latent period, or early symptomatic stage | ? | |
| 3. If the carriers of a mutation are identified as a result of screening, the natural history of people with this status should be understood, including the psychological implications | N/A | |
| 4. All the cost-effective primary prevention interventions should have been implemented as far as practicable | ? | |
| 5. There should be a simple, safe, precise, and validated screening test | X | |
| 6. The distribution of the test values in the target population should be known and a suitable cut-off level defined and agreed | X | |
| 7. The test should be acceptable to the population | ? | |
| 8. There should be an agreed policy on the further diagnostic investigation of individuals with a positive test result and on the choices available to those individuals | √ | |
| 9. If the test is for mutations, the criteria used to select the subset of mutations to be covered by screening, if all possible mutations are not being tested, should be clearly set out | N/A | |
| 10. There should be an effective treatment or intervention for patients identified through early detection, with evidence of early treatment leading to better outcomes than late treatment | √ | |
| 11. There should be agreed evidence-based policies covering which individuals should be offered treatment and the appropriate treatment to be offered | √ | |
| 12. Clinical management of the condition prior to participation in a screening program and patient outcomes should be optimized in all health care providers | ? | |
| 13. There should be evidence from high-quality randomized controlled trials that the screening program is effective at reducing mortality or morbidity | X | |
√ = criterion met.
X = criterion failed.
? = verdict uncertain.
N/A = criterion not applicable.